Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-Cell lymphoma

American Journal of Dermatopathology

Volumn 37, Issue 1, 2015, Pages 20-25

  Plaza, Jose A ^a   Sangueza, Martin ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Hospital Obrero   (Bolivia)

Author keywords

Cutaneous T cell lymphoma; Cytotoxic lymphomas; Epstein barr virus; Epstein barr virus associated lymphoma; Hydroa vacciniforme; Hydroa vacciniforme like lymphoma

Indexed keywords

ADOLESCENT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CD8+ T LYMPHOCYTE; CELLULITIS; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DERMIS; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS INFECTION; FEMALE; FEVER; HUMAN; HUMAN TISSUE; HYDROA VACCINIFORME; HYDROA VACCINIFORME LIKE LYMPHOMA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSECT BITE; LUPUS ERYTHEMATOSUS; LYMPHADENOPATHY; MALAISE; MALE; PERIORBITAL EDEMA; PRIORITY JOURNAL; RARE DISEASE; SCHOOL CHILD; SUBCUTANEOUS FAT; SYSTEMIC DISEASE; BIOPSY; CHEMISTRY; CLASSIFICATION; COMPLICATION; DIFFERENTIAL DIAGNOSIS; EDEMA; EPSTEIN BARR VIRUS; EPSTEIN-BARR VIRUS INFECTIONS; EYE NEOPLASMS; GENETICS; IN SITU HYBRIDIZATION; LYMPHOMA, T-CELL, CUTANEOUS; PATHOLOGY; PREDICTIVE VALUE; SKIN NEOPLASMS; VIROLOGY;

EPSTEIN-BARR VIRUS ENCODED RNA 1; TUMOR MARKER; VIRUS RNA;

ADOLESCENT; BIOPSY; CHILD; DIAGNOSIS, DIFFERENTIAL; EDEMA; EPSTEIN-BARR VIRUS INFECTIONS; EYE NEOPLASMS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; HYDROA VACCINIFORME; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOMA, T-CELL, CUTANEOUS; MALE; PREDICTIVE VALUE OF TESTS; RNA, VIRAL; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84922651862     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0000000000000158     Document Type: Article

References (16)

1. Sangueza M, Plaza JA. Hydroa vacciniforme-like cutaneous T-cell lymphoma: clinicopathologic and immunohistochemical study of 12 cases. J Am Acad Dermatol. 2013;69:112-119.
2. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2008.
3. Iwatsuki K, Ohtsuka M, Akiba H, et al. Atypical hydroa vacciniforme in childhood: from a smoldering stage to Epstein-Barr virus-associated lymphoid malignancy. J Am Acad Dermatol. 1999;40:283-284.
4. Magana M, Sangueza P, Gil-Beristain J, et al. Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): A distinctive type of cutaneous T-cell lymphoma. J Am Acad Dermatol. 1998;38: 574-579.
5. Iwatsuki K, Satoh M, Yamamoto T, et al. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol. 2006;142:587-595.
6. Wu YH, Chen HC, Hsiao PF, et al. Hydroa vacciniforme-like Epstein- Barr virus-associated monoclonal T-lymphoproliferative disorder in a child. Int J Dermatol. 2007;46:1081-1086.
7. Quintanilla-Martinez L, Ridaura C, Nagl F, et al. Hydroa vacciniformelike lymphoma: A chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma. Blood. 2013;122:3101-3110.
8. Barrionuevo C, Anderson VM, Zevallos-Giampietri E, et al. Hydroa-like cutaneous T-cell lymphoma: A clinicopathologic and molecular genetic study of 16 pediatric cases from Peru. Appl Immunohistochem Mol Morphol. 2002;10:7-14.
9. Ohshima K, Kimura H, Yoshino T, et al. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int. 2008;58:209-217.
10. Cho EY, Kim KH, Kim WS, et al. The spectrum of Epstein-Barr virusassociated lymphoproliferative disease in Korea: Incidence of disease entities by age groups. J Korean Med Sci. 2008;23:185-192.
11. Kimura H. Pathogenesis of chronic active Epstein-Barr virus infection: Is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol. 2006;16:251-261.
12. Mendoza N, Diamantis M, Arora A, et al. Mucocutaneous manifestations of Epstein-Barr virus infection. Am J Clin Dermatol. 2008;9:295-305.
13. Suzuki K, Ohshima K, Karube K, et al. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Int J Oncol. 2004;24:1165-1174.
14. Ruiz-Maldonado R, Parrilla FM, Orozco-Covarrubias ML, et al. Edematous, scarring vasculitic panniculitis: A new multisystemic disease with malignant potential. J Am Acad Dermatol. 1995;32: 37-44.
15. Quintanilla-Martinez L, Kimura H, Jaffe ES. EBV Positive T-cell Lymphoproliferative Disorders of Childhood. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008. 4th ed. Lyon, France: IARC press; 2008:278-260.
16. Doeden K, Molina-Kirsch H, Perez E, et al. Hydroa-like lymphoma with CD56 expression. J Cutan Pathol. 2008;35:488-494.